Fluoroquinolone antibiotics: reminder of the risk of disabling and potentially long-lasting or irreversible side effects. Drug Safety Update 2023;17:1. Medicines and Healthcare products Regulatory Agency. Fluoroquinolone antibiotics: suicidal thoughts and behaviour. Drug Safety Update 2023;17:2.Drug and...
The article offers information on the drug safety updates issued by the British Medicines and Healthcare products Regulatory Agency (MHRA). Healthcare professionals are being advised to voluntarily withdraw orciprenaline from the market in 2010 due to reports of cardiac adverse effects. Medical profes...
Email Updates Please confirm which of the FREE email services you would like to receive from us, you can unsubscribe at any time: newsletter-dailyPharmaceutical Business review Daily Update newsletter-weeklyPharmaceutical Business review Weekly Round-up magazinePharmaceutical Business review Magazine Confirma...
Other updates fall under conformityassessment requirements, underscoring the shift away from the previousessential requirements to MDR’s general safety and performance requirements.One update specifies a requirement in MDR that manufacturers mu...
Register for Journal Updates Editorial Board About This Journal Manuscript Submission Topics Drug Safety and Pharmacovigilance Pharmacology/Toxicology Industry Sectors Biotechnology Pharma Continue reading... To view the rest of this content please follow the download PDF link above.Over...
Other updates fall under conformityassessment requirements, underscoring the shift away from the previousessential requirements to MDR’s general safety and performance requirements.One update specifies a requirement in MDR that manufacturers must justify theinclusion of small amounts of substances classified...
For company updates and to learn more about Vertex's history of innovation, visit www.vrtx.com or follow us on LinkedIn, Facebook, Instagram, YouTube and Twitter/X. About CRISPR Therapeutics CRISPR Therapeutics is a leading gene editing company focused on developing transformative...
(OTC)inUK pharmacies.ThereisconcernthatPSEandEPHcanbeextractedfromthesemedicines andusedintheillegalmanufactureoftheClassAcontrolleddrugmethylamphetamine (commonlyknownas‘methamphetamine’,‘crystalmeth’or‘ice’).Becauseofthis concern,theMHRAheldapublicconsultationin2007onwhethertoreclassifyOTC medicinescontaining...
We continually review the safety of medicines and vaccines in the UK, and inform healthcare professionals and the public of the latest updates through several means, including public assessment reports. The following report presents the 2012 review of the impact of measures introduced to control the...
The article offers information on the drug safety updates issued by the British Medicines and Healthcare products Regulatory Agency (MHRA). Healthcare professionals are being advised to voluntarily withdraw orciprenaline from the market in 2010 due to reports o...